- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | BrightSpring Health Divests Community Living Business For $850 Million To Focus On Core Activities | 3 | Benzinga.com | ||
| Di | BrightSpring Health stock rises on divestiture plan | 1 | Investing.com | ||
| Di | BrightSpring Health-Aktie steigt nach Ankündigung von Veräußerungsplan | 1 | Investing.com Deutsch | ||
| Di | BrightSpring Health Services, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Di | BrightSpring divests community living business for $835M; raises FY24 revenue outlook | 2 | Seeking Alpha | ||
| Di | BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living | 30 | GlobeNewswire (Europe) | Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES Aktie jetzt für 0€ handeln | |||||
| 14.01. | BrightSpring Health Services, Inc. TANGIBLE EQUITY UNIT goes ex dividend tomorrow | 4 | Seeking Alpha | ||
| 11.12.24 | BrightSpring Health Services, Inc. Announced Refinancing of Term Loan B | 1 | GlobeNewswire (USA) | ||
| 11.12.24 | BrightSpring Health Services, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 26.11.24 | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Onco360 Has Been Selected as a Partner for Several New Drugs | 1 | GlobeNewswire (USA) | ||
| 15.11.24 | BrightSpring Health Services, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 06.11.24 | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi | 1 | GlobeNewswire (USA) | ||
| 04.11.24 | KeyBanc maintains Sector Weight on BrightSpring Health shares | 1 | Investing.com | ||
| 01.11.24 | BrightSpring Health Services, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 01.11.24 | BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | 404 | GlobeNewswire (Europe) | LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| 14.10.24 | BrightSpring Health announces CLO retirement and transition plan | 1 | Investing.com | ||
| 11.10.24 | BrightSpring Health Services, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.10.24 | KeyBanc beginnt Berichterstattung über BrightSpring-Aktien mit "Sector Weight"-Einstufung | 1 | Investing.com Deutsch | ||
| 11.10.24 | KeyBanc initiates coverage on BrightSpring shares with Sector Weight rating | 2 | Investing.com | ||
| 03.10.24 | BrightSpring Health stock bullish as specialty medication trends strengthen-BTIG | 1 | Investing.com |
Seite:
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 84,79 | -0,06 % | Medtronic Appoints Thierry Pieton As CFO | WASHINGTON (dpa-AFX) - Medtronic Plc (MDT), a healthcare technology company, said on Tuesday that it has appointed Thierry Pieton as its Chief Financial Officer with effect from March 3. Pieton... ► Artikel lesen | |
| INTUITIVE SURGICAL | 580,00 | +0,07 % | Soll ich diese Aktien jetzt kaufen? Intel, Intuitive Surgical und UnitedHealth im Check | In der neuesten Folge von "Money Train" begrüßen wir Martin Weiß, stellvertretender Chefredakteur bei DER AKTIONÄR. Gemeinsam analysieren wir die aktuelle Lage bei Intel, Intuitive Surgical und UnitedHealth... ► Artikel lesen | |
| THERMO FISHER | 550,70 | +0,16 % | MedMira mit zweiter Zulassung!: MedMira erhält von Health Canada Zulassung für Reveal® G4 Rapid HIV-1/2 Test | ||
| ROKU | 76,57 | +0,08 % | Roku Stock Is Rising After-Hours Tuesday: Here's Why | ||
| DEXCOM | 82,89 | +0,08 % | Deutliches Plus erfreut Inhaber der Dexcom-Aktie (80,80 €) | Zu den großen Gewinnern am Aktienmarkt zählt heute der Anteilsschein von Dexcom . Der Kurs des Wertpapiers legt kräftig zu. Die Dexcom-Aktie gehört heute mit einem Kursplus von 3,46 Prozent zu den Gewinnern... ► Artikel lesen | |
| RESMED | 238,90 | +0,42 % | Should you buy CSL and ResMed shares in January? | ||
| ATOSSA THERAPEUTICS | 0,797 | -4,44 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Full Results from Phase 2 KARISMA-Endoxifen Study Demonstrating Statistically Significant Reductions in Mammographic Breast Density | 1 MG Dose (Z)-Endoxifen Shows Potential as a Well-Tolerated, Preventative Therapy for Premenopausal Women at Risk of Developing Breast Cancer Data to be Presented in a Poster Spotlight Session During... ► Artikel lesen | |
| GE HEALTHCARE TECHNOLOGIES | 83,77 | -0,07 % | What to Expect From GE HealthCare's Q4 2024 Earnings Report | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
| ORGANON | 15,295 | +0,26 % | Organon & Co. - 8-K, Current Report | ||
| QUIDELORTHO | 41,400 | -1,43 % | QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024 | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care... ► Artikel lesen | |
| CENTENE | 60,51 | -0,98 % | $1000 Invested In Centene 15 Years Ago Would Be Worth This Much Today | ||
| TEMPEST THERAPEUTICS | 0,850 | -0,12 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC) | BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| VERU | 1,075 | +3,17 % | Stock Traders Purchase Large Volume of Veru Call Options (NASDAQ:VERU) | ||
| NANO-X IMAGING | 8,365 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen |
Das Unternehmen BRIGHTSPRING HEALTH SERVICES INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 20,890 Euro und damit +12,61 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRIGHTSPRING HEALTH SERVICES INC finden Sie auf Wallstreet Online.
